Test Claimants in the Franked Investment Income Group Litigation v IRC

Ironwood Pharmaceuticals Reports Third Quarter 2023 Results

Retrieved on: 
Thursday, November 9, 2023
Research, FDA, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, Other Science, Science, Graft-versus-host disease, United European Gastroenterology, Short bowel syndrome, Constipation, Trial of the century, Income tax, Interstitial cystitis, Hepatology, Interest expense, EBITDA, Test Claimants in the Franked Investment Income Group Litigation v IRC, Liver, STARS, GAAP, Acquisition, SBS, Interest, PBC, Society, Pharmacokinetics, Phase, Clinical trial, Annual general meeting, Primary biliary cholangitis, Autoimmune disease, Depreciation, UEG, Safety, Total, CIC, Patient, Endometriosis, Pharmaceutical industry, Vaccine, Video game, Bookkeeping, Reinsurance, Bank, Ironwood, Nutrition

Total revenues in the third quarter of 2023 were $113.7 million, compared to $108.6 million in the third quarter of 2022.

Key Points: 
  • Total revenues in the third quarter of 2023 were $113.7 million, compared to $108.6 million in the third quarter of 2022.
  • Operating expenses in the third quarter of 2023 were $73.7 million, compared to $40.2 million in the third quarter of 2022.
  • Adjusted EBITDA was $49.1 million in the third quarter of 2023, compared to $68.8 million in the third quarter of 2022.
  • – Ironwood generated approximately $32.5 million in cash from operations in the third quarter of 2023, compared to $69.1 million in cash from operations in the third quarter of 2022.

Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance

Retrieved on: 
Tuesday, August 8, 2023
Biotechnology, Other Health, Health, Pharmaceutical, Clinical Trials, Natural borrowing limit, SBS, Workforce, Endometriosis, Total, IPR, Income tax, Interest, Test Claimants in the Franked Investment Income Group Litigation v IRC, PBC, Graft-versus-host disease, Clinical trial, GAAP, Research, Interest expense, Functional constipation, Short bowel syndrome, Trial of the century, Interstitial cystitis, Primary biliary cholangitis, EBITDA, Acquisition, STARS, Patient, Autoimmune disease, Liver, Depreciation, Phase, FDA, Hand, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Safety, Pharmaceutical industry, Bank, Security (finance), Vaccine, Video game, Reinsurance, Bookkeeping, Ironwood

Ironwood intends to effect a squeeze-out merger under Swiss law to acquire the remaining outstanding VectivBio Shares in the second half of 2023.

Key Points: 
  • Ironwood intends to effect a squeeze-out merger under Swiss law to acquire the remaining outstanding VectivBio Shares in the second half of 2023.
  • Total revenues in the second quarter of 2023 were $107.4 million, compared to $97.2 million in the second quarter of 2022.
  • – Ironwood generated approximately $35.0 million in cash from operations in the second quarter of 2023, compared to $61.4 million in cash from operations in the second quarter of 2022.
  • Ironwood is increasing its 2023 U.S. LINZESS net sales and total revenue growth guidance and updating its adjusted EBITDA financial guidance.

Ironwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidance

Retrieved on: 
Thursday, May 4, 2023
Research, Clinical Trials, Biometrics, Other Health, Health, Pharmaceutical, General Health, Other Science, Science, Endometriosis, Income tax, Senior, Interest, Test Claimants in the Franked Investment Income Group Litigation v IRC, PBC, New Drug Application, Constipation, GAAP, Functional constipation, Trial of the century, IC/BPS, Interstitial cystitis, Primary biliary cholangitis, Shanda, EBITDA, Patient, AbbVie, Autoimmune disease, PDUFA, Liver, Depreciation, Ageing, Phase, FDA, Total, Safety, Pharmaceutical industry, Video game, Bookkeeping, Security (finance), Reinsurance, Ironwood

On April 10, 2023, Ironwood determined to eliminate the role of chief operating officer to streamline the executive leadership team.

Key Points: 
  • On April 10, 2023, Ironwood determined to eliminate the role of chief operating officer to streamline the executive leadership team.
  • Total revenues in the first quarter of 2023 were $104.1 million, compared to $97.5 million in the first quarter of 2022.
  • Operating expenses in the first quarter of 2023 were $44.0 million, compared to $39.7 million in the first quarter of 2022.
  • – Ironwood generated $80.2 million in cash from operations in the first quarter of 2023, compared to $64.1 million in cash from operations in the first quarter of 2022.

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results

Retrieved on: 
Thursday, February 16, 2023
Research, FDA, Clinical Trials, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Science, Other Science, New Drug Application, Trial of the century, Shanda, Test Claimants in the Franked Investment Income Group Litigation v IRC, Constipation, PDUFA, Safety, Expense, EBITDA, Patient, GAAP, Liver, Total, Interstitial cystitis, Conversion, Primary biliary cholangitis, Autoimmune disease, Phase, Interest, PBC, Share repurchase, Functional constipation, Derivative, Endometriosis, Depreciation, AbbVie, Asus, Ageing, Pharmaceutical industry, Video game, Security (finance), Cryptocurrency, Life insurance, Reinsurance, Bookkeeping, IC/BPS, Ironwood

Total revenues in the fourth quarter of 2022 were $107.2 million, compared to $117.1 million in the fourth quarter of 2021.

Key Points: 
  • Total revenues in the fourth quarter of 2022 were $107.2 million, compared to $117.1 million in the fourth quarter of 2021.
  • Operating expenses in the fourth quarter of 2022 were $38.8 million, compared to $60.5 million in the fourth quarter of 2021.
  • Adjusted EBITDA was $68.7 million in the fourth quarter of 2022, compared to $57.0 million in the fourth quarter of 2021.
  • – Ironwood generated $79.2 million in cash from operations in the fourth quarter of 2022, compared to $64.6 million in cash from operations in the fourth quarter of 2021.

Sustainable Home Decor Global Market to Reach $556.3 Billion by 2031 at a CAGR of 5.5% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 14, 2022
Home Goods, Environment, Retail, Specialty, Sustainability, Benchmarking, Market share, Textile, Library, Green, Price point, Restaurant, Porter's five forces analysis, Distribution, Test Claimants in the Franked Investment Income Group Litigation v IRC, Retail, Interior design

The global sustainable home decor market was valued at $331.0 billion in 2021, and is projected to reach $556.3 billion by 2031, growing at a CAGR of 5.5% from 2022 to 2031.

Key Points: 
  • The global sustainable home decor market was valued at $331.0 billion in 2021, and is projected to reach $556.3 billion by 2031, growing at a CAGR of 5.5% from 2022 to 2031.
  • Due to the numerous vendors in both worldwide and regional competitors, the global market for sustainable home decor is highly fragmented.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the sustainable home decor market analysis from 2021 to 2031 to identify the prevailing sustainable home decor market opportunities.
  • The report includes the analysis of the regional as well as global sustainable home decor market trends, key players, market segments, application areas, and market growth strategies.

The Worldwide DIY Home Decor Industry is Expected to Reach $372,060 Billion by 2031 - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 8, 2022
Construction & Property, Interior Design, Benchmarking, Market share, Textile, Transport, Environment, Camping, Price point, DIY, Restaurant, Growth, Porter's five forces analysis, Distribution, Test Claimants in the Franked Investment Income Group Litigation v IRC, Interior design, Construction

The global do it yourself (DIY) home decor market was valued at $240,635 billion in 2021, and is estimated to reach $372,060 billion by 2031, registering a CAGR of 4.7% from 2022 to 2031.

Key Points: 
  • The global do it yourself (DIY) home decor market was valued at $240,635 billion in 2021, and is estimated to reach $372,060 billion by 2031, registering a CAGR of 4.7% from 2022 to 2031.
  • The DIY home decor market is highly fragmented due to the presence of multiple vendors in both international and regional players.
  • Developing real estate industry drives the growth of the global DIY home decor market in the current scenario.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the diy home decor market analysis from 2021 to 2031 to identify the prevailing diy home decor market opportunities.

Bridge Investment Group Holdings Inc. Reports Second Quarter 2022 Results

Retrieved on: 
Monday, August 8, 2022
Construction & Property, REIT, U.S. Securities and Exchange Commission, Income, Investor relations, NYSE, Private Securities Litigation Reform Act, Security (finance), Test Claimants in the Franked Investment Income Group Litigation v IRC, Company, Webcast, Telephone number (mathematics), Investor, Time, Interest, Conference, Financial services, Video game, Bank, Bridge

Bridge Investment Group Holdings Inc. (NYSE: BRDG) (Bridge or the Company) today reported its financial results for the second quarter ended June 30, 2022.

Key Points: 
  • Bridge Investment Group Holdings Inc. (NYSE: BRDG) (Bridge or the Company) today reported its financial results for the second quarter ended June 30, 2022.
  • Total Revenue and Investment Income were $99.0 million and $104.9 million, respectively, for the quarter ended June 30, 2022.
  • Bridge Investment Group Holdings Inc. issued a full detailed presentation of its second quarter 2022 results, which can be viewed on the Investors section of our website at www.bridgeig.com .
  • Interested parties may access the conference call live over the phone by dialing 1-877-405-1210 (Toll Free) or 1-201-689-8721 (Toll/International) and requesting Bridge Investment Group Holdings Inc.s Second Quarter 2022 Earnings Conference Call.

Bridge Investment Group Holdings Inc. Reports First Quarter 2022 Results

Retrieved on: 
Monday, May 9, 2022
Construction & Property, REIT, U.S. Securities and Exchange Commission, Income, Investment, Private Securities Litigation Reform Act, Interest, Company, NYSE, Telephone number (mathematics), Time, Security (finance), Webcast, Investor relations, Conference, AUM, Test Claimants in the Franked Investment Income Group Litigation v IRC, East Coast (train operating company), Investor, Video game, Bridge

Bridge Investment Group Holdings Inc. (NYSE: BRDG) (Bridge or the Company) today reported its financial results for the first quarter ended March 31, 2022.

Key Points: 
  • Bridge Investment Group Holdings Inc. (NYSE: BRDG) (Bridge or the Company) today reported its financial results for the first quarter ended March 31, 2022.
  • Net Income applicable to Bridge Investment Group Holdings LLC (the Operating Company) was $97.5 million for the quarter ended March 31, 2022, compared to $40.7 million for the quarter ended March 31, 2021, representing a 140% increase year-over-year.
  • Additionally, strong investment performance year-to-date and another successful fundraising quarter for Bridge totaling $1.1 billion represent a solid beginning for 2022.
  • Bridge Investment Group Holdings Inc. issued a full detailed presentation of its first quarter 2022 results, which can be viewed on the Investors section of our website at www.bridgeig.com .

Bridge Investment Group Holdings Inc. Reports Fourth Quarter and Full Year 2021 Results

Retrieved on: 
Wednesday, March 2, 2022
Professional Services, Other Professional Services, Other Construction & Property, Residential Building & Real Estate, Commercial Building & Real Estate, Finance, Construction & Property, Momentum, Private Securities Litigation Reform Act, Investor, Income, Security (finance), AUM, U.S. Securities and Exchange Commission, Growth, NYSE, Webcast, Company, Time, Conference, Interest, East Coast (train operating company), Investor relations, Test Claimants in the Franked Investment Income Group Litigation v IRC, Telephone number (mathematics), Video game, Animal, Financial services, Bridge

Bridge Investment Group Holdings Inc. (NYSE: BRDG) (Bridge or the Company) today reported financial results for its fourth quarter and full year ended December 31, 2021.

Key Points: 
  • Bridge Investment Group Holdings Inc. (NYSE: BRDG) (Bridge or the Company) today reported financial results for its fourth quarter and full year ended December 31, 2021.
  • Total Revenue and Investment Income were $107.3 million and $148.3 million, respectively, for the quarter ended December 31, 2021.
  • Net Income applicable to Bridge Investment Group Holdings LLC (the Operating Company) was $165.8 million for the quarter ended December 31, 2021, compared to $92.5 for the quarter ended December 31, 2020.
  • Bridge Investment Group Holdings Inc. issued a full detailed presentation of its fourth quarter and full year 2021 results, which can be viewed at www.bridgeig.com on the Investors section of our home page.

Bridge Investment Group Holdings Inc. Reports Third Quarter 2021 Results

Retrieved on: 
Thursday, November 11, 2021
Professional Services, Finance, Telephone number (mathematics), AUM, Private Securities Litigation Reform Act, Investor, Security (finance), Test Claimants in the Franked Investment Income Group Litigation v IRC, Investment, Growth, East Coast (train operating company), Conference, U.S. Securities and Exchange Commission, Company, IPO, NYSE, Webcast, Time, Interest, Income, Financial services, Commercial property

Bridge Investment Group Holdings Inc. (NYSE: BRDG) (Bridge or the Company) today reported its financial results for its third quarter ended September 30, 2021.

Key Points: 
  • Bridge Investment Group Holdings Inc. (NYSE: BRDG) (Bridge or the Company) today reported its financial results for its third quarter ended September 30, 2021.
  • Total Revenue and Investment Income for Bridge Investment Group Holdings LLC (the Operating Company) were $92.2 million and $84.9 million, respectively, for the quarter ended September 30, 2021.
  • Robert Morse, Bridges Executive Chairman, commented that, Bridge delivered another quarter of strong results, based on record capital raising and deployment across our investment verticals.
  • Bridge Investment Group Holdings Inc. issued a full detailed presentation of its third quarter 2021 results, which can be viewed at www.bridgeig.com on the Investors section of our home page.